Literature DB >> 7574534

Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts.

M Fresta1, A Spadaro, G Cerniglia, I M Ropero, G Puglisi, P M Furneri.   

Abstract

In order to incorporate ofloxacin within liposomes, the reverse-phase evaporation technique was carried out. The liposome lipid matrix consisted of dipalmitoylphosphatidylcholine-cholesterol-dihexadecylphosphate (4: 3:4 molar ratio). The liposome formulation presented a mean size of 185 +/- 31 nm and had an encapsulation capacity of 5.3 microliters/mumol. The liposome formulation was able to deliver ofloxacin into McCoy cells in a greater amount (2.6-fold) than the free drug, improving antibiotic accumulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574534      PMCID: PMC162745          DOI: 10.1128/AAC.39.6.1372

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Liposomes in antimicrobial chemotherapy.

Authors:  V J Richardson
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

Review 2.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

3.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

4.  Interaction of intraleukocytic bacteria and antibiotics.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

5.  Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes.

Authors:  A Forsgren; A Bellahsène
Journal:  Scand J Infect Dis Suppl       Date:  1985

6.  Intracellular penetration and antimicrobial activity of antibiotics.

Authors:  R F Jacobs; C B Wilson
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

7.  Antibiotic entry into human polymorphonuclear leukocytes.

Authors:  R C Prokesch; W L Hand
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

8.  Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency.

Authors:  S Benita; P A Poly; F Puisieux; J Delattre
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

9.  Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin.

Authors:  J V Desiderio; S G Campbell
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

10.  Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis.

Authors:  J V Desiderio; S G Campbell
Journal:  J Reticuloendothel Soc       Date:  1983-10
View more
  4 in total

1.  Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.

Authors:  P M Furneri; M Fresta; G Puglisi; G Tempera
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.

Authors:  M S Webb; N L Boman; D J Wiseman; D Saxon; K Sutton; K F Wong; P Logan; M J Hope
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  Efficacy of Levofloxacin Loaded Nonionic Surfactant Vesicles (Niosomes) in a Model of Pseudomonas aeruginosa Infected Sprague Dawley Rats.

Authors:  Satish Jankie; Jenelle Johnson; Amusa Sarafadeen Adebayo; Gopal Krishna Pillai; Lexley Maureen Pinto Pereira
Journal:  Adv Pharmacol Pharm Sci       Date:  2020-10-27

4.  Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.

Authors:  Reem E Alarfaj; Manal M Alkhulaifi; Ahmed J Al-Fahad; Shokran Aljihani; Alaa Eldeen B Yassin; Majed F Alghoribi; Majed A Halwani
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.